News and Information

Investor

Ausun Pharmaceutical Featured API Project Public Reference Description


Release Date:

2020-07-21

Ausun Pharmaceutical Featured API Project Public Reference Explanation

Related News

Leading the Peptide Pipeline: Aoxiang Pharmaceutical Deeply Engages in Discussions on Reaction Safety Risk Assessment, Jointly Mapping Out the Industry’s Blueprint

In recent years, Aoxiang Pharmaceutical has, while maintaining its core strengths in active pharmaceutical ingredients, steadfastly implemented a “transformation and upgrading” strategy, prioritizing the research and development of peptide drugs, oligonucleotides, and synthetic biology technologies.

2026-01-13